Xencor Obtains $7,597,653 New Funding Round

  • Feed Type
  • Date
    7/2/2013
  • Company Name
    Xencor
  • Mailing Address
    111 West Lemon Avenue Monrovia, CA 91016
  • Company Description
    In collaboration with our partners — including leading biotechnology company Genentech and pharmaceutical company Eli Lilly — we are selectively designing next-generation protein drug candidates with improved selectivity, efficacy and safety.
  • Website
    http://www.xencor.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $7,597,653
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.